[Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
D002752:Chlorthalidone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D054833:Isoindoles; D008297:Male; D008875:Middle Aged; D010096:Oxprenolol / Q000627:therapeutic use*; D000096926:Benzenesulfonamides
D002752:Chlorthalidone; D004338:Drug Combinations; D006830:Hydralazine; D054833:Isoindoles; D010096:Oxprenolol; C039267:trepress; D000096926:Benzenesulfonamides
Behandlung schwer einstellbarer Hypertoniker mit einer fixen Oxprenolol/Chlortalidon/Hydralazin-Kombination. Ergebnisse einer offenen multizentrischen Prüfung.